Document is current
Any future updates will be listed below
-
Authors
Zhang, Henghui
Han, Sisi
Su, Zhengming
Zheng, Zaosong
Ru, Dejun
Xu, Bihong
Jiang, Xianhan
Zhao, Fengjin
-
Funding
Funding for this research was provided by:
the Characteristic Innovation Project of Department of Education of Guangdong Province (2023KTSCX107)
Basic and Applied Basic Research Foundation of Guangdong Province (2023A03J0422)
Guangzhou Major Medical Discipline Project (2005-2007)
Major technical projects of Guangzhou (2026C-ZD013)
The National Natural Science Fund of China (82072808)
- License Information
-
More Information
Article History
Received: 16 December 2025
Accepted: 6 February 2026
First Online: 20 February 2026
Declarations
:
: This study follows the declaration of Helsinki. A BCa tissue microarray (TMA) was obtained from Shanghai Outdo Biotech Co., Ltd. (Shanghai, China), with ethical approval granted by the company’s Institutional Review Board (Ethics Approval No. YBL20250514). The subcutaneous xenograft tumor model was approved by the Institutional Animal Care and Use Committee (IACUC) of (Huawei Testing Co., Ltd., Guangdong, China) (Protocol No. HWT-BG-117b).
: All authors are aware of and agree to publish the content of the paper.
: The authors declare that no conflicts of interest exist.
